Cutting the Gordian Helix - Regulating Genomic Testing in the Era of Precision Medicine.

Author information

Abstract

In his 2015 State of the Union address, President Barack Obama announced a new Precision Medicine Initiative (PMI), a national investment in research on approaches to disease treatment and prevention that take into account individual variability in each person's genes, environment, and lifestyle. In a recent Perspective article, Francis Collins and Harold Varmus sketched out initial ideas for the PMI research plans as envisioned by the National Institutes of Health (NIH).1 But scientific progress alone won't guarantee that the public reaps the full benefits of precision medicine - an achievement that, as Collins and Varmus note, "will also require advancing . . .